Journal of Crohns & Colitis
Journal Abbreviation: J CROHNS COLITIS
ISSN: 1873-9946
Publisher: Elsevier
Publications (73)
Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study (2018)
Panaccione R, Atreya R, Ferrante M, Dubinsky MC, Sands BE, Abreu MT, Cataldi F, et al.
Conference contribution
Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018)
Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al.
Conference contribution
Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis (2018)
Konturek P, Zopf Y, Dieterich W, Wirtz S, Neurath M, Brzozowski T
Conference contribution
Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY (2018)
Bossuyt P, Atreya R, Taxonera C, Hebuterne X, Isaacs K, Higgins PD, Lindsay J, et al.
Conference contribution
IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018)
Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al.
Conference contribution
Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation (2018)
Zundler S, Becker E, Spocinska M, Parga-Vidal L, Stark R, Atreya R, Rath T, et al.
Conference contribution
IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitis (2018)
Zundler S, Spocinska M, Popp V, Becker E, Atreya R, Neufert C, Atreya I, et al.
Conference contribution
Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease (2018)
Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, Van 'T Wout AB, Atreya R, et al.
Journal article
Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018)
Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al.
Conference contribution
Alpha 4 beta 7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages (2018)
Schleier L, Wiendl M, Binder MT, Atreya R, Watson A, Neufert C, Atreya I, et al.
Conference contribution